Article Insiders Have Bought 40 Million Shares.. (( resd ))
Motley Fool 2 Biotechs to Avoid, 1 to Buy
By Mohsin Saeed - May 23, 2013
During the last six months, insiders have purchased approximately 40 million shares of the company. This has increased insider holdings by 95%. During the same period, institutional investors have also increased their holdings by 14%. , MannKind is still trading below i's mean target price, which I think makes it worth a closer look.